EU API Makers Fight Substandard Imports by Requesting Asia Supplier Inspections
This article was originally published in PharmAsia News
Executive Summary
Two years after the European Union established good manufacturing practices requirements for active pharmaceutical ingredients, finished product manufacturers are routinely auditing their API suppliers - but regulatory agencies should be inspecting them too, argue EU API makers in a bid to keep out substandard APIs from Asia